A survey amongst the UK pulmonary hypertension community has shown overwhelming support for the development of a soft robotic heart that aims to reduce deaths from heart failure.
3 June 2021
The PHA UK has launched a new survey to help researchers who are looking at the use of cutting-edge remote monitoring technology to help patients get the best results from their medication.
18 March 2021
PRESS RELEASE: People living with the rare lung disease pulmonary hypertension saw their physical health deteriorate whilst shielding, according to a new report.
1 November 2020A message on behalf of the UK’s specialist centres PH patients have been shielded during the COVID19 pandemic. Consequently in March, the UK centres all agreed to suspend blood testing for everyone prescribed an Endothelin receptor antagonist (Ambrisentan, Bosentan or Macitentan) . The current government advice is for shielding to end on August 1st. […]
3 July 2020A letter from the UK’s specialist PH centres and the PHA UK As a result of the coronoavirus pandemic, there has been a huge rise in global demand for cleaning and hygiene equipment. Shortages of gowns and masks have been well publicised in the media and everyone in healthcare has a duty to use protective […]
30 April 2020
The pulmonary hypertension treatment SLOZEM® (which contains Diltiazem) is no longer available for patients – but alternative brands are available.
26 February 2020
